CRT 2026

Panel Discussion

Moderator(s)

• 

  Ernest Spitzer, MD

  Chief Executive Officer
  Cardialysis B.V.
  Rotterdam, Zuid-Holland, Netherlands

  Disclosure(s): Abbott Vascular: Grant/Research Support (Ongoing); Biosensors Europe: Grant/Research Support (Ongoing); Boston Scientific Corporation: Grant/Research Support (Ongoing); Edward Lifesciences: Grant/Research Support (Ongoing); Medtronic Inc: Grant/Research Support (Ongoing); Novo Nordisk A/S: Grant/Research Support (Ongoing); Philips Medical: Grant/Research Support (Ongoing); Pie Medical Imaging: Grant/Research Support (Ongoing); Siemens Healthineers AG: Grant/Research Support (Ongoing)
• 

  David A. Morrow, MD

  Director, Levine Cardiac Intensive Care Unit
  Brigham and Women's Hospital

  Disclosure(s): 4TEEN4: Grant/Research Support (Ongoing); Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Abiomed: Grant/Research Support (Ongoing); Amgen: Grant/Research Support (Ongoing); Anthos Therapeutics: Grant/Research Support (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Daiichi Sankyo: Grant/Research Support (Ongoing); Merck & Co.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Novartis Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Pfizer: Grant/Research Support (Ongoing); Regeneron Pharmaceuticals Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Roche Diagnostics: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Panel Discussant(s)

• 

  Daniel Burkhoff, MD, PhD

  Director: Heart Failure, Hemodynamics and MCS Research
  Cardiovascular Research Foundation
  New York, New York, United States

  Disclosure(s): Abiomed / Johnson & Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); OrchestraBiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)
• 

  Donald E. Cutlip, MD, FACC

  Vice Chair, Department of Medicine
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States

  Disclosure(s): Cordis Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)
• 

  Jacob Eifer Møller, MD

  Consultant
  Rigshospitalet Copenhagen Denmark

  Disclosure(s): Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Magenta,: Consulting Fees (e.g., advisory boards) (Ongoing)
• CR

  Christine Rutan

  Disclosure information not submitted.
• 

  Alexander G. Truesdell, MD

  Interventional Cardiology
  Virginia Heart / Inova Schar Heart and Vascular
  McLean, Virginia, United States

  Disclosure(s): Abiomed: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Chiesi: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Getinge: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Ron Waksman, MD, MSCAI

  Director, Cardiovascular Research and Advanced Education
  MedStar Washington Hospital Center, MedStar Heart and Vascular Institute
  Washington, District of Columbia, United States

  Disclosure information not submitted.